ARQUES has sold Rohner to BluO
ARQUES Industries AG, Stranberg, Germany sold its shares in the subsidiary Rohner AG, Pratteln, Switzerland in a package deal to the Luxembourg based Private Equity company BluO. Rohner AG is a Switzerland based premier Custom Manufacturer (CMO) of Active Pharmaceutical Ingredients (APIs) and specialty chemical intermediates on a custom synthesis and toll manufacturing basis for leading pharmaceutical and specialty chemical companies. The Company has been part of the ARQUES investment portfolio since March 2006. The previous owner of Rohner had already announced the shutdown of production. Under the management of ARQUES Industries AG, Rohner was already operating profitably after less than 18 months and is now on a sustainable growth course.
Lincoln International AG advised ARQUES Industries AG as exclusive financial advisor in connection with the divestiture of its shares in Rohner AG. In the case of questions or more information please call the project director, Dr. Dietmar Nienstedt.
View More Transactions
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.